It has been reported that GS decreases the expression of gene products involved in proliferation (cyclin D1 and c-myc) by inhibition of NF-κB and IκBα kinase activation in human cells derived from lung carcinoma and leukaemia (Shishodia and Aggarwal, 2004). The gene discussed is NFKB1; the disease is lung carcinoma.